YungShin Global Holding Corporation (TPE: 3705)

Market Cap	15.02B
Revenue (ttm)	7.44B
Net Income (ttm)	1.05B
Shares Out	266.36M
EPS (ttm)	3.95
PE Ratio	14.27
Forward PE	n/a
Dividend	2.30 (4.06%)
Ex-Dividend Date	Jun 24, 2024

Volume	465,137
Open	55.70
Previous Close	55.70
Day's Range	55.70 - 57.30
52-Week Range	43.40 - 58.70
Beta	0.03
Analysts	n/a
Price Target	n/a
Earnings Date	Sep 11, 2024

About YungShin Global Holding

YungShin Global Holding Corporation, through its subsidiaries, invests in, manufactures, and sells medicines, animal drugs, agricultural chemicals, industrial medicines, and cosmetics in Taiwan, Mainland China, Japan, and the United States. It also engages in the extraction, manufacture, and sale of wood products; manufacture and sale of over-the-counter drugs, preparations, and chemical intermediates; and pharmaceutical research, transfer, and authorization services, as well as import and export trading. In addition, the company is involved in...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1952
• Country: Taiwan
• Stock Exchange: Taiwan Stock Exchange
• Ticker Symbol: 3705

Financial Performance

In 2023, YungShin Global Holding's revenue was 7.03 billion, a decrease of -3.88% compared to the previous year's 7.31 billion. Earnings were 827.30 million, a decrease of -1.40%.